Anne Schuchat

Anne Schuchat's AcademicInfluence.com Rankings

Anne Schuchat

Philosophy

#5452

World Rank

#8256

Historical Rank

Logic

#2731

World Rank

#3762

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Anne Schuchat's Degrees

Doctorate Medicine University of Illinois College of Medicine

Why Is Anne Schuchat Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Anne Schuchat's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. (2010) (2722)
DEPARTMENT OF HEALTH & HUMAN SERVICES (2015) (1657)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. (2003) (1550)
Epidemiology of human listeriosis. (2007) (1299)
Bacterial meningitis in the United States in 1995. Active Surveillance Team. (1997) (1247)
COVID-19: towards controlling of a pandemic (2020) (1174)
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. (2000) (989)
Quitting smoking among adults--United States, 2001-2010. (2011) (983)
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. (2000) (921)
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. (2006) (839)
Active bacterial core surveillance of the emerging infections program network. (2001) (744)
Prevention of perinatal group B streptococcal disease : a public health perspective (1996) (727)
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. (2001) (703)
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. (2008) (687)
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. (2000) (644)
Bacterial meningitis in the United States, 1998-2007. (2005) (641)
Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms (1998) (629)
Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings (2002) (626)
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. (2000) (614)
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study (2006) (602)
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. (2002) (574)
Epidemiology of human listeriosis (1991) (493)
The changing epidemiology of meningococcal disease in the United States, 1992-1996. (1999) (482)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. (1993) (434)
Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). (2011) (426)
Risk Factors and Opportunities for Prevention of Early-Onset Neonatal Sepsis: A Multicenter Case-Control Study (1999) (352)
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. (2002) (352)
PREVENTION OF PERINATAL GROUP B STREPTOCOCCAL DISEASE (2002) (339)
Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 (2020) (337)
Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. (1992) (305)
Evaluation of universal antenatal screening for group B streptococcus. (2009) (295)
Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. (1992) (293)
Risk Factors for Group B Streptococcal Disease in Adults (1995) (268)
Serogroup C meningococcal outbreaks in the United States. An emerging threat. (1995) (261)
Group B streptococcus (1999) (253)
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. (1999) (249)
Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24–April 21, 2020 (2020) (249)
Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. (1990) (243)
Benefits from Immunization During the Vaccines for Children Program Era — United States, 1994–2013 (2014) (240)
New Data on Opioid Use and Prescribing in the United States. (2017) (238)
Prevalence and awareness of HIV infection among men who have sex with men --- 21 cities, United States, 2008. (2010) (237)
Superspreading SARS Events, Beijing, 2003 (2004) (235)
Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. (1994) (235)
Early-onset neonatal sepsis in the era of group B streptococcal prevention. (2001) (228)
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. (2003) (224)
Seasonal Patterns of Invasive Pneumococcal Disease (2003) (223)
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2009) (222)
Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. (1998) (218)
Outbreaks of salmonellosis associated with eating uncooked tomatoes: implications for public health (1999) (213)
Maternal carriage of group B streptococci in developing countries. (1998) (211)
Invasive group B streptococcal disease: the emergence of serotype V. (1996) (208)
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. (2002) (198)
Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen (2002) (197)
The Accuracy of Late Antenatal Screening Cultures in Predicting Genital Group B Streptococcal Colonization at Delivery (1996) (197)
Role of Foods in Sporadic Listeriosis: II. Microbilogic and Epidemiologic Investigation (1992) (197)
Global strategies to prevent bacterial pneumonia in adults with HIV disease. (2004) (193)
Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. (1994) (189)
A foodborne outbreak of gastroenteritis involving Listeria monocytogenes (1996) (188)
Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. (2000) (187)
Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. (1999) (185)
Perinatal infections due to group B streptococci. (2004) (184)
Comparison of prevention strategies for neonatal group B streptococcal infection: A population‐based economic analysis (1993) (181)
Toxic shock syndrome in the United States: surveillance update, 1979 1996. (1999) (181)
Changes in Invasive Pneumococcal Disease among HIV-Infected Adults Living in the Era of Childhood Pneumococcal Immunization (2006) (178)
Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. (2005) (177)
Risk Factors for SARS among Persons without Known Contact with SARS Patients, Beijing, China (2004) (177)
Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment (2005) (174)
Recommendations from the National Vaccine Advisory Committee: Standards for Adult Immunization Practice (2014) (165)
An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. (2003) (150)
Prevalence of coronary heart disease--United States, 2006-2010. (2011) (149)
Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010. (2011) (149)
Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. (2001) (147)
Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. (1992) (142)
Increased risk of meningitis and bacteremia due to Listeria monocytogenes in patients with human immunodeficiency virus infection. (1993) (142)
Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. (2002) (136)
Risk Factors for Invasive, Early-Onset Escherichia coli Infections in the Era of Widespread Intrapartum Antibiotic Use (2006) (136)
Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. (2002) (136)
Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. (2005) (132)
The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. (2000) (131)
Invasive Group A Streptococcal Disease: Risk Factors for Adults (2003) (131)
Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group. (1995) (130)
Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. (2004) (130)
Decline in Sepsis-associated Neonatal and Infant Deaths in the United States, 1979 Through 1994 (1998) (127)
Characteristics associated with HIV infection among heterosexuals in urban areas with high AIDS prevalence --- 24 cities, United States, 2006-2007. (2011) (126)
Comparison of ribotyping and multilocus enzyme electrophoresis for subtyping of Listeria monocytogenes isolates (1994) (122)
Listeria monocytogenes Contamination of Turkey Franks: Evaluation of a Production Facility. (1990) (119)
The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. (1996) (119)
Prenatal screening for infectious diseases and opportunities for prevention. (2003) (119)
First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities — May 2014 (2014) (117)
Invasive Group B Streptococcal Disease in Adults: A Population-Based Study in Metropolitan Atlanta (1991) (113)
Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. (2002) (113)
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. (2010) (111)
Perinatal group B streptococcal disease. (2007) (109)
Vaccination and Perinatal Infection Prevention Practices Among Obstetrician–Gynecologists (2003) (107)
Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger (2000) (104)
Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. (2006) (104)
A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates (2003) (103)
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. (1992) (100)
Prevalence of abnormal lipid levels among youths --- United States, 1999-2006. (2010) (100)
Epidemic nephritis in Nova Serrana, Brazil (2000) (97)
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial (2009) (97)
Prevention of Varicella: Recommendations for Use of Varicella Vaccines in Children, Including a Recommendation for a Routine 2-Dose Varicella Immunization Schedule (2007) (95)
Inhalational Anthrax Outbreak among Postal Workers, Washington, D.C., 2001 (2002) (95)
Locally acquired Dengue--Key West, Florida, 2009-2010. (2010) (94)
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves (1999) (91)
Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. (2000) (90)
Group B streptococcal disease: from trials and tribulations to triumph and trepidation. (2001) (88)
Outbreak of neonatal listeriosis associated with mineral oil. (1991) (86)
Epidemiology of Pneumococcal Infections in the Elderly (1999) (82)
Age-Dependent Neisseria meningitidis Serogroup C Class-Specific Antibody Concentrations and Bactericidal Titers in Sera from Young Children from Montana Immunized with a Licensed Polysaccharide Vaccine (1998) (81)
Trends in Sepsis-Related Neonatal Mortality in the United States, 1985–1998 (2004) (80)
Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women. (2001) (78)
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization (2010) (77)
Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population. (1991) (76)
Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use (2010) (75)
Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. (2003) (74)
Severe Acute Respiratory Syndrome, Beijing, 2003 (2004) (72)
Vaccine-preventable diseases, immunizations, and MMWR--1961-2011. (2011) (71)
School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. (1997) (71)
Risk Factors for Pediatric Invasive Group A Streptococcal Disease (2005) (71)
Impact of Conjugate Vaccine on Transmission of Antimicrobial-Resistant Streptococcus pneumoniae Among Alaskan Children (2008) (69)
Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003. (2008) (69)
Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007–2008 (2008) (67)
Prevention of perinatal group B streptococcal infection: current controversies. (2000) (67)
Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. (2002) (66)
A multistate outbreak of sporotrichosis associated with sphagnum moss. (1992) (66)
Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. (2008) (65)
Increased prevalence of pediatric pneumococcal serotypes in elderly adults. (2005) (65)
Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. (2003) (65)
Cigarette package health warnings and interest in quitting smoking --- 14 countries, 2008--2010. (2011) (65)
Disease Surveillance and the Academic, Clinical, and Public Health Communities (2003) (64)
Implementing an Ebola Vaccine Study - Sierra Leone. (2016) (64)
Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique (2006) (64)
The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV[INCREMENT]G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak (2018) (64)
Increased transmission and outbreaks of measles, European Region, 2011. (2011) (63)
Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy. (2000) (63)
Neonatal group B streptococcal disease--screening and prevention. (2000) (61)
Gastrointestinal carriage of Listeria monocytogenes in household contacts of patients with listeriosis. (1993) (60)
Opportunities for Prevention of Perinatal Group B Streptococcal Disease: A Multistate Surveillance Analysis (1997) (60)
Infection Prevention and Control in Pediatric Ambulatory Settings (2007) (60)
Meningococcal disease in Los Angeles County, California, and among men in the county jails. (1996) (59)
Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. (2009) (59)
Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. (2010) (59)
Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. (2002) (57)
Adherence to Antimicrobial Inhalational Anthrax Prophylaxis among Postal Workers, Washington, D.C., 2001 (2002) (56)
Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. (2001) (55)
Adult use of prescription opioid pain medications - Utah, 2008. (2010) (53)
Invasive group B streptococcal disease in Maryland nursing home residents. (2001) (52)
Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010. (2010) (51)
Comparison of cold enrichment and U.S. Department of Agriculture methods for isolating Listeria monocytogenes from naturally contaminated foods. The Listeria Study Group (1991) (51)
Public health issues related to infection in pregnancy and cerebral palsy. (2002) (50)
Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. (1995) (49)
Comparison of Three Selective Enrichment Methods for the Isolation of Listeria monocytogenes from Naturally Contaminated Foods. (1992) (49)
The science behind preparing and responding to pandemic influenza: the lessons and limits of science. (2011) (48)
Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. (2001) (48)
Risk factors for invasive pneumococcal disease among Navajo adults. (2007) (47)
Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States. (2001) (47)
Cigarette use among high school students - United States, 1991-2009. (2010) (47)
Bullying among middle school and high school students--Massachusetts, 2009. (2011) (44)
Effects of Hospital Policies Based on 1996 Group B Streptococcal Disease Consensus Guidelines (2000) (44)
Outbreak of early onset Group B streptococcal sepsis (1993) (42)
Neonatal Group B Streptococcal Disease: How Infection Control Teams Can Contribute to Prevention Efforts (2000) (42)
Prevention of Human Papillomavirus Infection: Provisional Recommendations for Immunization of Girls and Women With Quadrivalent Human Papillomavirus Vaccine (2007) (42)
Acute illnesses associated with insecticides used to control bed bugs--seven states, 2003--2010. (2011) (41)
A population‐based assessment of invasive disease due to group B streptooccus in nonpregnant adults (1994) (40)
Zika Virus 6 Months Later. (2016) (40)
Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States. (2003) (38)
Hepatitis C among drug users: déjà vu all over again? (2001) (38)
Fatal laboratory-acquired infection with an attenuated Yersinia pestis Strain--Chicago, Illinois, 2009. (2011) (38)
Outbreaks following wild poliovirus importations --- Europe, Africa, and Asia, January 2009-September 2010. (2010) (38)
Impact of a risk-based prevention policy on neonatal group B streptococcal disease. (1998) (37)
HIV Transmitted from a Living Organ Donor—New York City, 2009 (2011) (35)
Prevention practices for perinatal group B streptococcal disease: A multi‐state surveillance analysis (1997) (35)
Human Vaccines and Their Importance to Public Health (2011) (35)
Barriers to prevention of perinatal group B streptococcal disease. (1995) (34)
Prevention of neonatal sepsis. (2005) (34)
Adults with invasive pneumococcal disease: missed opportunities for vaccination. (2006) (33)
Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes --- United States and Puerto Rico, 1996-2007. (2010) (32)
Self-reported influenza-like illness during the 2009 H1N1 influenza pandemic--United States, September 2009 - March 2010. (2011) (32)
Monitoring the impact of vaccines postlicensure: new challenges, new opportunities (2008) (31)
Infections in International Pregnancy Study: Performance of the Optical Immunoassay Test for Detection of Group B Streptococcus (2003) (31)
Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger. (2004) (31)
First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities—May 2014 (2014) (31)
Immunization in the United States (2008) (30)
Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger. (1998) (30)
Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children. (2010) (29)
Recommended Immunization Schedules for Children and Adolescents—United States, 2008 (2008) (27)
Sentinel Surveillance: A Reliable Way To Track Antibiotic Resistance in Communities? (2002) (27)
Group B Streptococcal Disease Prevention Practices of Obstetrician‐Gynecologists (2001) (27)
Work-related fatalities associated with tree care operations--United States, 1992-2007. (2009) (24)
Population-Based Surveillance in San Francisco and Atlanta Trends in Incidence and Antimicrobial Resistance of Early-Onset Sepsis: (2005) (24)
Group B streptococcal disease in newborns: a global perspective on prevention. (1995) (24)
Impact of intrapartum antibiotics on the care and evaluation of the neonate (2003) (24)
HPV "coverage". (2015) (23)
Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service. (2011) (22)
Protecting the Public's Health: Critical Functions of the Section 317 Immunization Program—A Report of the National Vaccine Advisory Committee (2013) (22)
Toxic shock syndrome and tampons. (1991) (22)
Prevention of perinatal group B streptococcal infections. (1999) (21)
2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care - New York City, 2009. (2010) (20)
1997 AAP guidelines for prevention of early-onset group B streptococcal disease. (1997) (20)
From pandemic suspect to the postvaccine era: the Haemophilus influenzae story. (2007) (19)
Disease surveillance for the COVID-19 era: time for bold changes (2021) (19)
Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (2018) (19)
Improving the Health of the United States With a "Winnable Battles" Initiative. (2017) (19)
Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia (2005) (19)
Pneumonia in children in the developing world: New challenges, new solutions (2004) (17)
"Choking game" awareness and participation among 8th graders--Oregon, 2008. (2010) (17)
Invasive group-A streptococcal infection in an allograft recipient. A case report. (2007) (17)
Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally. (2013) (17)
Epidemiology of Group B Streptococcal Infections (2006) (17)
Listeriosis and pregnancy: food for thought. (1997) (16)
Integrated Monitoring of a New Group B Streptococcal Disease Prevention Program and Other Perinatal Infections (2002) (16)
Racial/ethnic disparities among children with diagnoses of perinatal HIV infection - 34 states, 2004-2007. (2010) (15)
Report from the CDC. Awareness of perinatal group B streptococcal infection among women of childbearing age in the United States, 1999 and 2002. (2003) (15)
Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. (2002) (15)
Chlorhexidine Maternal-Vaginal and Neonate Body Wipes in Sepsis and Vertical Transmission of Pathogenic Bacteria in South Africa: A Randomized, Controlled Trial (2010) (15)
Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. (2004) (14)
Guidelines for prevention of perinatal group B streptococcal disease. (1996) (14)
Listeria monocytogenes CAMP reaction (1991) (13)
Global health and the US Centers for Disease Control and Prevention (2014) (12)
Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. (2005) (12)
The truth about PHEICs (2019) (12)
Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) (2015) (11)
Generic protocol for population-based surveillance of Haemophilus influenzae type B Prepared (1998) (11)
The value of science in integration of services. (2012) (11)
Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections (2015) (11)
Reflections on pandemics, past and present (2011) (10)
Meningococcal vaccine in sub-Saharan Africa (1997) (10)
The 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. American Academy of Pediatrics. (1997) (10)
Haemophilus influenzae type B infection. (1998) (9)
Preventing neonatal Group B streptococcal disease: The role of the clinical microbiology laboratory (1997) (9)
Hospital, heal thyself. (1997) (9)
Impact of intrapartum chemoprophylaxis on neonatal sepsis. (2003) (9)
Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015 (2018) (9)
Barriers to implementing the group B streptococcal prevention guidelines. (2002) (8)
Pneumococcal Prevention Gets Older and Wiser. (2015) (7)
Strengthening the evidence base for decisions on public health and social measures (2021) (7)
Documentation and verification of measles, rubella and congenital rubella syndrome elimination in the region of the Americas : United States national report, March 28, 2012 (2012) (7)
Television and video viewing time among children aged 2 years - Oregon, 2006-2007. (2010) (6)
Invasive group A streptococcus in a skilled nursing facility--Pennsylvania, 2009-2010. (2011) (6)
A human papillomavirus type 16 vaccine. (2003) (6)
Ethical Issues Associated With Routine Screening and Prophylaxis for Group B Streptococcus in Pregnancy (1996) (6)
Centers for Control and Prevention (2013) (6)
Delivering Pneumococcal Vaccine to a High Risk Population: The Navajo Experience (2005) (6)
1918 and 2009: A Tale of Two Pandemics (2010) (5)
Meningococcal vaccine in sub-Saharan Africa [letter] (1997) (4)
The End of Human Papillomavirus Vaccine Exceptionalism. (2018) (4)
The CDC's Recommendations to Help Prevent Fetal Alcohol Spectrum Disorders. (2017) (4)
The state of immunization 2013: we are the world. (2013) (4)
The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease. (1998) (3)
Public health response to influenza (2018) (3)
Protecting adults from influenza: tis the season to learn from the pandemic. (2012) (3)
Emerging and Reemerging Infectious Disease Threats (2014) (3)
Adult Group B Streptococcal Disease (1996) (3)
Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era. (2016) (3)
Perinatal Group B Streptococcal Disease Prevention, Minnesota (2005) (3)
Baseline Asymptomatic Malaria Infection and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccine: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE). (2021) (2)
Microbes without borders: infectious disease, public health, and the journal. (2000) (2)
Prescription Drug Monitoring Programs and Opioid Death Rates-Reply. (2017) (2)
Update on emerging infections: news from the Centers for Disease Control and Prevention. Emergence of Cryptococcus gattii--Pacific Northwest, 2004-2010. (2011) (2)
Multistaie population-based assessment of drug resistant S. pneumoniae mortality (1997) (2)
Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein (2)
HPV vaccine can’t wait: Immunization of younger teens is critical to preventing serious cancers later in life (2012) (1)
Therapy and outcomes of meningitis caused by drug-resistant Streptococcus pneumoniae (SP) in three U.S. cities, 1994-1996 (1997) (1)
Leveraging Rapid Response Activities to Build Public Health Capacity: Development of the Opioid Rapid Response Team Model. (2022) (1)
The Public Health Response and Epidemiologic Investigation Related to the Opening of a Bacillus anthracis–Containing Envelope, Capitol Hill, Washington, D.C. (2002) (1)
Readability of H1N1 Information From the CDC Web Site (2010) (1)
Group B Streptococci: from Emerging Infection to Prevention Success Story (2000) (1)
67 – Immunization in the United States (2013) (1)
Charles C. Shepard Science Awards 2018 : Innovation & creativity in modern public health : June 14, 2018 • 10:00 A.M. to 11:30 P.M (2018) (0)
Measles in our time: the US experience. (2015) (0)
Human methane production: a study of population groups and environmental factors in Israel. (1986) (0)
Impact (Intended and Unintended) of Prophylaxis on Pediatric Infectious Diseases (2003) (0)
A Masterwork of Art, a Metaphor for Prevention (2018) (0)
Contributors (2008) (0)
Late Breaking Updates on Pathogens - Old and New (2015) (0)
Appreciating Teachers, Asking for Your Help (2022) (0)
SocioeconomicandRacial/EthnicDisparitiesintheIncidence ofBacteremicPneumoniaAmongUSAdults (2010) (0)
Comparison ofRibotyping andMultilocus EnzymeElectrophoresis forSubtyping ofListeria monocytogenes Isolates (1994) (0)
The US Centers for Disease Control: a crucial actor in global health (2014) (0)
Beginnings and Endings: A Retiree’s Reflections on the CDC’s Undergraduate Public Health Scholars Program (2021) (0)
8. Seeliger HPR, Hohne K. Serotyping of Listeria monocytogenes and re- (1993) (0)
CDC’s response to the Zika virus (2016) (0)
Health and Humanitarian Logistics : Transforming Global Health and Humanitarian Systems (2016) (0)
Implementation of group B Streptococcus prevention strategy. Authors' reply (2002) (0)
Early opportunities for prevention: infections of pregnant women and young infants. (2001) (0)
Preventing complications from 2009 influenza A (H1N1) in persons with underlying lung diseases: a formidable challenge for 2010 Year of the Lung. (2010) (0)
Group B Strep: Successful Model of "From Science to Action" (2004) (0)
Toxic Shock Syndrome in the United States : Surveillance Update , 1979-1996 1 (2019) (0)
Development of a meningococcal A/C conjugate vaccine (1997) (0)
Perinatal group B streptococcal disease: The next generation of prevention (2003) (0)
HPV Vaccination Uptake in the United States: Missed Opportunities and other Related Challenges (2014) (0)
In appreciation: Abram S. 'Bud' Benenson, MD (2000) (0)
Aspirin for primary cardiovascular prevention : RIP (2019) (0)
Epidemiologic typing of Streptococcus pneumoniae invasive isolates from South Texas (1997) (0)
ADULT GROUP B STREPTOCOCCAL DISEASE. AUTHORS' REPLY (1996) (0)
Contributors (2015) (0)
Controlling and responding to mosquito-borne illnesses : state and local panel (2016) (0)
Guest Commentary (2022) (0)
Contents (2005) (0)
Reporting of toxic shock syndrome. (1992) (0)
Data Errors in the Text and Tables. (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Anne Schuchat?

Anne Schuchat is affiliated with the following schools:

University of California, Berkeley